This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04956692
Brief Title: Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
First Submitted : July 6, 2021
First Submitted that Met QC Criteria : July 6, 2021
First Posted : July 9, 2021
Last Update Submitted that Met QC Criteria : August 31, 2023
Last Update Posted : September 5, 2023